Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Fifty-two eyes of 52 patients with treatment-naïve macular edema associated with perfused branch retinal vein occlusion were retrospectively reviewed. Twenty-seven cases received PRN intravitreal bevacizumab, and 25 cases were treated by PRN intravitreal aflibercept with monthly follow-ups for 12 mo...

Full description

Bibliographic Details
Main Authors:	Jia-Kang Wang, Pei-Yuan Su, Yung-Ray Hsu, Yun-Ju Chen, Fang-Ting Chen, Ying-Yu Tseng
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2016/8421940

id	doaj-1385eb48c0c54c51b9bafcac7ed2b52d
record_format	Article
spelling	doaj-1385eb48c0c54c51b9bafcac7ed2b52d2020-11-25T01:39:08ZengHindawi LimitedJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/84219408421940Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein OcclusionJia-Kang Wang0Pei-Yuan Su1Yung-Ray Hsu2Yun-Ju Chen3Fang-Ting Chen4Ying-Yu Tseng5Department of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Section 2, Nan-Ya South Road, Pan-Chiao District, New Taipei City 220, TaiwanDepartment of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Section 2, Nan-Ya South Road, Pan-Chiao District, New Taipei City 220, TaiwanDepartment of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Section 2, Nan-Ya South Road, Pan-Chiao District, New Taipei City 220, TaiwanDepartment of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Section 2, Nan-Ya South Road, Pan-Chiao District, New Taipei City 220, TaiwanDepartment of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Section 2, Nan-Ya South Road, Pan-Chiao District, New Taipei City 220, TaiwanDepartment of Ophthalmology, Far Eastern Memorial Hospital, No. 21, Section 2, Nan-Ya South Road, Pan-Chiao District, New Taipei City 220, TaiwanFifty-two eyes of 52 patients with treatment-naïve macular edema associated with perfused branch retinal vein occlusion were retrospectively reviewed. Twenty-seven cases received PRN intravitreal bevacizumab, and 25 cases were treated by PRN intravitreal aflibercept with monthly follow-ups for 12 months. Both aflibercept and bevacizumab were effective in reduction of macular thickness and improvement of visual acuity for the participants. Both antivascular endothelial growth factor agents had similar efficacy and duration of treatment for these eyes with macular edema secondary to branch retinal vein occlusion during a 12-month period. No serious systemic or ocular adverse events were reported.http://dx.doi.org/10.1155/2016/8421940
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Jia-Kang Wang Pei-Yuan Su Yung-Ray Hsu Yun-Ju Chen Fang-Ting Chen Ying-Yu Tseng
spellingShingle	Jia-Kang Wang Pei-Yuan Su Yung-Ray Hsu Yun-Ju Chen Fang-Ting Chen Ying-Yu Tseng Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion Journal of Ophthalmology
author_facet	Jia-Kang Wang Pei-Yuan Su Yung-Ray Hsu Yun-Ju Chen Fang-Ting Chen Ying-Yu Tseng
author_sort	Jia-Kang Wang
title	Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
title_short	Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
title_full	Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
title_fullStr	Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
title_full_unstemmed	Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
title_sort	comparison of the efficacy of intravitreal aflibercept and bevacizumab for macular edema secondary to branch retinal vein occlusion
publisher	Hindawi Limited
series	Journal of Ophthalmology
issn	2090-004X 2090-0058
publishDate	2016-01-01
description	Fifty-two eyes of 52 patients with treatment-naïve macular edema associated with perfused branch retinal vein occlusion were retrospectively reviewed. Twenty-seven cases received PRN intravitreal bevacizumab, and 25 cases were treated by PRN intravitreal aflibercept with monthly follow-ups for 12 months. Both aflibercept and bevacizumab were effective in reduction of macular thickness and improvement of visual acuity for the participants. Both antivascular endothelial growth factor agents had similar efficacy and duration of treatment for these eyes with macular edema secondary to branch retinal vein occlusion during a 12-month period. No serious systemic or ocular adverse events were reported.
url	http://dx.doi.org/10.1155/2016/8421940
work_keys_str_mv	AT jiakangwang comparisonoftheefficacyofintravitrealafliberceptandbevacizumabformacularedemasecondarytobranchretinalveinocclusion AT peiyuansu comparisonoftheefficacyofintravitrealafliberceptandbevacizumabformacularedemasecondarytobranchretinalveinocclusion AT yungrayhsu comparisonoftheefficacyofintravitrealafliberceptandbevacizumabformacularedemasecondarytobranchretinalveinocclusion AT yunjuchen comparisonoftheefficacyofintravitrealafliberceptandbevacizumabformacularedemasecondarytobranchretinalveinocclusion AT fangtingchen comparisonoftheefficacyofintravitrealafliberceptandbevacizumabformacularedemasecondarytobranchretinalveinocclusion AT yingyutseng comparisonoftheefficacyofintravitrealafliberceptandbevacizumabformacularedemasecondarytobranchretinalveinocclusion
_version_	1725050319141863424

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Similar Items